Understanding how cell interactions contribute to lung disease fibrosis
Cell-cell and cell-matrix interactions driving progressive fibrosis in interstitial lung diseases
['FUNDING_U01'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-10975694
This study is looking at how different cells in the lungs work together to cause scarring in interstitial lung diseases, especially in the early stages, to help find new ways to treat the condition.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-10975694 on ClinicalTrials.gov |
What this research studies
This research investigates the mechanisms behind progressive fibrosis in interstitial lung diseases (ILDs) by examining the interactions between airway epithelial cells, mesenchymal cells, and the surrounding matrix. Using advanced techniques like spatial transcriptomics and 3D cell culture models, the study aims to explore how these cellular interactions drive the progression of fibrosis at different stages of the disease. By focusing on early ILD lesions, the research seeks to uncover the initiating factors that contribute to lung damage and fibrosis, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with interstitial lung diseases, particularly those in the early stages of the condition.
Not a fit: Patients with advanced or end-stage interstitial lung disease may not benefit from this research as it focuses on early disease mechanisms.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients suffering from interstitial lung diseases.
How similar studies have performed: While there has been significant research on end-stage ILD, this approach focusing on early lesions and cellular interactions is relatively novel and has not been extensively tested.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOMPERTS, BRIGITTE N — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: GOMPERTS, BRIGITTE N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.